School of medicine

Clinical practice names new CEO

Paul Taheri MD has joined the School of Medicine as deputy dean and chief executive officer of Yale Medical Group (YMG), following a nationwide search. Taheri was previously the senior associate dean for clinical affairs and president and CEO of the University of Vermont (UVM) Medical Group in Burlington, as well as a professor of surgery at UVM. There, he was responsible for overseeing and managing a 500-member multispecialty practice with more than 1,000 staff and $250 million in annual revenue. He has been credited with preparing the group, both financially and operationally, for the future of health care reform. Taheri received his undergraduate degree from St. Lawrence University and his medical degree from New York University, then completed his general surgical residency at Tulane University. 

Prize honors immigrant scientists

Two immune-system researchers at the School of Medicine will share one of the 2013 Vilcek Prizes, awards that recognize significant contributions to American science and the arts made by immigrants. Richard A. Flavell, chair and Sterling Professor of Immunobiology, and Ruslan M. Medzhitov, David A. Wallace Professor of Immunobiology, were honored for their long-standing and influential work on the innate immune system, the first line of defense against infection by bacteria and viruses. Flavell, who was born in the United Kingdom, came to Yale in 1988 to lead its immunobiology program. Medzhitov, a member of the Yale faculty since 1999, is a native of Tashkent, Uzbekistan. The prizes carry a cash award of $100,000.

The comment period has expired.